Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

TCBP

TC BioPharm (TCBP)

TC BioPharm Holdings PLC
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TCBP
일자시간출처헤드라인심볼기업
2024/09/2105:00PR Newswire (US)/C O R R E C T I O N -- TC BioPharm/NASDAQ:TCBPTC BioPharm Holdings PLC
2024/09/1221:30PR Newswire (US)TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical TrialNASDAQ:TCBPTC BioPharm Holdings PLC
2024/09/0921:30PR Newswire (US)TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey PoxNASDAQ:TCBPTC BioPharm Holdings PLC
2024/09/0705:00PR Newswire (US)TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey PoxNASDAQ:TCBPTC BioPharm Holdings PLC
2024/09/0521:30PR Newswire (US)TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:TCBPTC BioPharm Holdings PLC
2024/09/0321:30PR Newswire (US)TCBP Announces Dosing of 5 New Patients in ACHIEVENASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/3104:52Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/3006:11Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/2907:32Edgar (US Regulatory)Form F-1MEF - Registration statement to add securities to prior Form F-1 registration [Rule 462(b)]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/2906:15PR Newswire (US)TC BioPharm Announces Closing of Upsized $6.0 Million Public OfferingNASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/2902:50PR Newswire (US)TC BioPharm Announces Grant of European Patent Covering Use of Modified Gamma Delta Cells for the Treatment of Cancer and Viral IndicationsNASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/2406:30Edgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/2405:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/1705:20Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/1602:00PR Newswire (US)TC BioPharm Regains Compliance with Nasdaq Listing Rule 5550(b)NASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/1600:30PR Newswire (US)TC BioPharm Announces Closing of $2.0 Million Public OfferingNASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/1523:47Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/1420:30Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/1405:30PR Newswire (US)TC BioPharm Announces Pricing of $2.0 Registered Direct OfferingNASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/1313:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/0905:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/0705:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/07/3121:00PR Newswire (US)TCBP Announces Plan to Implement ADS Ratio ChangeNASDAQ:TCBPTC BioPharm Holdings PLC
2024/07/3005:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/07/2221:00PR Newswire (US)TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid LeukemiaNASDAQ:TCBPTC BioPharm Holdings PLC
2024/05/1521:30PR Newswire (US)TCBP Announces Launch of Compassionate Use Program for TCB008NASDAQ:TCBPTC BioPharm Holdings PLC
2024/05/0702:01PR Newswire (US)TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross ProceedsNASDAQ:TCBPTC BioPharm Holdings PLC
2024/05/0621:30PR Newswire (US)TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T TherapiesNASDAQ:TCBPTC BioPharm Holdings PLC
2024/04/0421:32PR Newswire (US)TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform TechnologiesNASDAQ:TCBPTC BioPharm Holdings PLC
2024/04/0221:30PR Newswire (US)TCBP Increasing Treatment Capacity with Expanded Manufacturing ProcessNASDAQ:TCBPTC BioPharm Holdings PLC
 검색 관련기사 보기:NASDAQ:TCBP